Skip to main content
. 2008 Mar 18;93(6):2109–2114. doi: 10.1210/jc.2007-2266

Table 1.

Karyotype and GH treatment in TS

GH use 45,X Mosaica 46,X,iXq 46,X,delXp 46,X,delXq Totals
No 10 (17%) 10 (30%) 3 (21%) 1 (14%) 2 (40%) 26
Yes 49 23 11 6 3 76
Totals 59 33 14 7 5 102

The percentages indicate the proportion of each karyotype group not treated with GH. 

a

A mosaic karyotype was significantly associated with nonuse of GH in a logistic regression model including race and age at diagnosis.